U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C15H22N2O.ClH
Molecular Weight 282.809
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MEPIVACAINE HYDROCHLORIDE, (S)-

SMILES

Cl.CN1CCCC[C@H]1C(=O)NC2=C(C)C=CC=C2C

InChI

InChIKey=RETIMRUQNCDCQB-ZOWNYOTGSA-N
InChI=1S/C15H22N2O.ClH/c1-11-7-6-8-12(2)14(11)16-15(18)13-9-4-5-10-17(13)3;/h6-8,13H,4-5,9-10H2,1-3H3,(H,16,18);1H/t13-;/m0./s1

HIDE SMILES / InChI
Molecular Formula C15H22N2O
Molecular Weight 246.348
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED
Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Dexivacaine is a local anesthetic drug that has minimal and non-significant side effects.

Approval Year

Unknown
149124
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Not Provided
511
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Clinical evaluation of the (+) isomer of mepivacaine.
1975-10
Patents

Patents

JP2000247873A
2
JP2000513737A
7
JP2000516204A
66
JP2001354554A
4
JP2001516714A
14
JP2002541203A
7
JP2003512401A
5
JP2005343890A
4
JP2005507882A
14
JP2005525136A
36
JP2005535563A
67
JP2006042693A
4
JP2006500966A
36
JP2006505569A
69
JP2006513267A
7
JP2006515994A
12
JP2006520801A
6
JP2007503428A
35
JP2009526755A
475
JP2010536873A
31
JP3497513B2
5
JP4141953B2
26
JP4467789B2
6
JP4667369B2
16
JPH07118126A
26

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:52:30 GMT 2025
Edited
by admin
on Mon Mar 31 17:52:30 GMT 2025
Record UNII
Q6359QUC5E
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
(+)-MEPIVACAINE MONOHYDROCHLORIDE
Preferred Name English
MEPIVACAINE HYDROCHLORIDE, (S)-
Common Name English
(S)-(+)-MEPIVACAINE MONOHYDROCHLORIDE
Common Name English
2-PIPERIDINECARBOXAMIDE, N-(2,6-DIMETHYLPHENYL)-1-METHYL-, MONOHYDROCHLORIDE, (S)-
Common Name English
(2S)-N-(2,6-DIMETHYLPHENYL)-1-METHYLPIPERIDINE-2-CARBOXAMIDE HYDROCHLORIDE
Systematic Name English
2-PIPERIDINECARBOXAMIDE, N-(2,6-DIMETHYLPHENYL)-1-METHYL-, HYDROCHLORIDE (1:1), (2S)-
Systematic Name English
DEXIVACAINE HYDROCHLORIDE
Common Name English
2',6'-PIPECOLOXYLIDIDE, 1-METHYL-, MONOHYDROCHLORIDE, (+)-
Common Name English
Code System Code Type Description
FDA UNII
Q6359QUC5E
Created by admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID90735374
Created by admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
PRIMARY
CAS
34333-71-6
Created by admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
PRIMARY
PUBCHEM
66586222
Created by admin on Mon Mar 31 17:52:31 GMT 2025 , Edited by admin on Mon Mar 31 17:52:31 GMT 2025
PRIMARY
Related Record Type Details
Structure of DEXIVACAINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966